GlobeNewsWire
10 Dec 2025, 13:00 UTC · 41w ago
Verdict
Headline leans bearish. We score ABSI +0.80.
Score contradicts the headline.
Leans bearish
From its wording — no explicit rating
+0.80strongly bullish
Which stocks this story touches
More positive than 86% of ticker scores this week
The company announced a high-profile partnership, presented positive preclinical data for its ABS-201 antibody, and highlighted a significant market opportunity for hair loss treatment.
Continue reading
5 related stories
More positive than 86% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+176.8%
Price agrees with the score
$9.74 vs $3.52 close before publication (Dec 9) · not market-adjusted
ABSI chart →
